Recursion Pharmaceuticals

Recursion Pharmaceuticals

Recursion Pharmaceuticals

Combining experimental biology and bioinformatics to identify 100 new treatmentsin 10 years.
Type
B2c
Founded
2013
Raised
$339.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$20,500,000
Debt financing - 2018
Square 1 Bank
Team Size
10+
Employees
$239,000,000 Venture capital (Series D)
FinSMEs

Recursion Raises $239M in Series D Equity Financing

Forbes Tech

Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery

$20,500,000 Debt financing
FinSMEs

Recursion Pharmaceuticals Raises $20.5M Credit Facility from Square 1 Bank

Funding Science Intelligent machines
$60,000,000 Venture capital (Series B)
TechCrunch , PE HUB

Drug discovery startup Recursion raises $60 million in Series B from Data Collective 

Funding Intelligent machines Health
$4,000,000 Debt financing
FinSMEs

Recursion Pharmaceuticals Receives $4M Credit Facility from Square 1 Bank

$2,150,000 Venture capital (Series A)
businesswire

Recursion Raises Additional Funding, Bringing Total Series A to $15.05M for Drug Discovery | Business Wire

$12,900,000 Venture capital (Series A)
businesswire , FinSMEs

Recursion Pharmaceuticals Raises $13M to Discover New Drugs Using Artificial Intelligence | Business Wire